Systematic Financial Management LP Bausch Health Companies Inc. Transaction History

Systematic Financial Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $243,808 - $329,830	-16,385 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $4,791 - $7,383	-360 Reduced 2.15%	16,385 $300,000
Q1 2020 May 12, 2020	SELL	$12.98 - $30.25 $61,265 - $142,780	-4,720 Reduced 21.99%	16,745 $260,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $81,604 - $137,764	-4,320 Reduced 16.75%	21,465 $642,000
Q3 2019 Nov 06, 2019	SELL	$20.88 - $25.66 $217,152 - $266,864	-10,400 Reduced 28.74%	25,785 $563,000
Q2 2019 Jul 26, 2019	SELL	$20.52 - $26.45 $269,222 - $347,024	-13,120 Reduced 26.61%	36,185 $913,000
Q1 2019 May 03, 2019	BUY	$20.23 - $26.29 $43,393 - $56,392	2,145 Added 4.55%	49,305 $1.22 Million
Q4 2018 Feb 13, 2019	SELL	$17.64 - $28.32 $157,966 - $253,605	-8,955 Reduced 15.96%	47,160 $871,000
Q3 2018 Nov 06, 2018	BUY	$20.64 - $25.67 $1.16 Million - $1.44 Million	56,115 New	56,115 $1.44 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.